Cognivue

03/02/2026

⏳ This Thursday
Join Dr. Jake R. Carpenter-Thompson, MD, PhD, leading sports neurologist and concussion expert at The Kutcher Clinic for Sports Neurology, for the webinar:
"Rewriting the Concussion Protocol: How Cognivue Enhances Cognitive Evaluation & Recovery Planning"

📅 March 5, 2026 | 🕐 1 PM EST / 10 AM PST

Dr. Carpenter-Thompson will discuss the evolving science of sports-related concussion and the role of objective cognitive assessment in baseline testing, post-injury evaluation, and recovery planning.

If you’re involved in sports medicine, neurology, or concussion management, register now to join us.

👉 https://bit.ly/4cS8AwP

02/26/2026

Don’t miss this valuable Hearing Healthcare learning opportunity at the 2026 Preventing Decline Summit (March 20–21, 2026 | Scottsdale, AZ).

Hosted by AuDExperts, this 4th Annual Summit brings together some of the world’s highest-rated private practices to explore the neuroscience model of hearing healthcare—focused on patient health literacy and building a strong physician referral system.

Cognivue is proud to be a sponsor of this event, which aligns closely with our mission to advance early detection of cognitive impairment and address modifiable risk factors—hearing loss being the #1 modifiable risk factor.

Learn more and register at: https://bit.ly/4aROJeq

02/24/2026

Optimal Vision ( )! Research has found the relationship between cognitive decline and vision impairment may be a modifiable risk factor [1]. To manage or prevent vision impairment, schedule regular visits with your vision healthcare provider.



Reference: 1. Hajek A et al. Effect of visual impairment on physical and cognitive function in old age: findings of a population-based prospective cohort study in Germany. J Am Ger Soc. 2016;64(11):2311- 2316.

02/19/2026

Rethinking how cognitive performance is measured.

Both Cognivue Clarity® and Cognivue Thrive® are powered by adaptive psychophysics—a technology that personalizes testing in real time.

The system:
➡️ Calibrates to an individual’s motor and visual abilities
➡️ Dynamically adjusts task difficulty as performance changes
➡️ Measures cognitive performance across progressively challenging levels

Rather than relying on a static set of questions, the technology continuously adapts to the individual—helping deliver objective, performance-based insights into cognitive function.

Innovation isn’t about adding more questions.
It’s about measuring smarter.

02/12/2026

Rewriting the Concussion Protocol: How Cognivue Enhances Cognitive Evaluation & Recovery Planning

📅 March 5, 2026 | 🕐 1 PM EST/ 10 AM PST

Join us for a special webinar featuring Dr. Jake R. Carpenter-Thompson, MD, PhD, leading sports neurologist and concussion expert at The Kutcher Clinic for Sports Neurology — in conversation with Dr. Joy Siegel, EdD, MBA.

Dr. Carpenter-Thompson will explore the evolving science of sports-related concussion, the importance of diagnostic clarity, and how objective cognitive assessment with Cognivue Clarity® can support baseline testing, post-injury evaluation, and recovery planning.

If you’re involved in sports medicine, neurology, or concussion management, you won’t want to miss this.

👉 Register here: https://bit.ly/4rcXRBj

02/05/2026

⏳ Two weeks to go, join us for an important conversation on emotional well-being and cognitive health.

Mood changes, withdrawal, anxiety, and irritability can be early indicators of cognitive change in aging adults, yet they are easy to overlook in busy clinical settings.

On February 19, join clinical neuropsychologist Dr. Ruth Morin, PhD, in conversation with Dr. Joy Siegel, EdD, MBA, for a practical discussion on how emotional well-being and cognitive health intersect—and why routine cognitive monitoring matters across care settings.

📅 February 19, 2026 | ⏰ 1:00 PM EST | 10:00 AM PST

👉 Register here:
https://bit.ly/4r6TzeD

Cognivue

01/29/2026

Highly relevant reading for anyone interested in the intersection of cognitive assessment and emerging biomarkers.

In the NeurologyLive interview “Predicting Amyloid Positivity with CARM: Clinical Insights from James Galvin, MD, MPH,” James E. Galvin, MD, MPH discusses how findings from the landmark Bio-Hermes study, sponsored by the Global Alzheimer’s Platform Foundation, informed the development of the Cognivue Amyloid Risk Measure (CARM).

CARM is designed to be interpreted alongside the overall Cognivue Clarity® cognitive assessment score, adding context to cognitive screening by helping predict the likelihood of amyloid pathology. In the interview, Dr. Galvin explains how this combined approach can support clinical decision-making and research trial screening, while fitting into existing workflows.

The article offers a practical look at how cognitive assessment and amyloid risk insights can work together to inform next steps in both clinical and research settings.

🔗 Read the full interview:
https://bit.ly/4q7IHw1

The professor of neurology at the Miami Miller School of Medicine discussed how the Cognivue Amyloid Risk Measure (CARM) may help predict amyloid presence and informs diagnosis, trial eligibility, and early treatment pathways.

01/27/2026

Sleep and Relax ( )! Insufficient sleep can not only make a person irritable, but it can also affect memory and decision making. Healthy adults need between 7 and 9 hours of sleep per night.

01/21/2026

🧠 Emotional Well-Being and the Aging Brain: What Every Provider Needs to Know

How often do early cognitive changes show up as emotional or behavioral concerns—and are we catching them soon enough?

Join clinical neuropsychologist Dr. Ruth Morin, PhD, in conversation with public health expert Dr. Joy Siegel, EdD, MBA, for a timely and practical discussion on the critical link between emotional well-being and cognitive health in aging adults.

Drawing on Dr. Morin’s extensive clinical and research experience in neuropsychology, this Cognivue webinar will explore why routine monitoring of cognitive and emotional changes is essential across healthcare settings—and how providers can integrate cognitive screening into everyday workflows without adding burden.

📅 February 19, 2026 | ⏰ 1:00 PM EST | 10:00 AM PST

👉 Register here:
https://bit.ly/4qwboUr

01/14/2026

Now live: Cognivue’s Education Page for HCP education.

We’re excited to make it easier to browse a growing set of on-demand webinars and clinical learning resources in one place. More additions to come.

Visit the learning library: https://bit.ly/49CSO5I

01/08/2026

Did you know nearly half of dementia cases may be preventable?

The 2024 Lancet Commission reports that 45% of dementia cases are potentially preventable by addressing 14 modifiable risk factors, many of which develop across early life, midlife, and later years. [1]

Cognivue is committed to supporting brain health with tools that help identify cognitive changes earlier. That is why proactive brain health matters, and why early cognitive screening can be an important step in identifying changes sooner, when intervention, planning, and support may have the greatest impact.

Let’s keep building awareness around prevention, risk reduction, and earlier insight.



Reference:
[1] Livingston G, Huntley J, Liu K, et al. (2024). Dementia Prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 404(10452), 572–628. DOI: 10.1016/S0140-6736(24)01296-0.

12/30/2025

As 2025 comes to a close, we reflect on a year defined by our continued commitment to advancing cognitive health.

At the heart of this work is a belief that earlier, richer cognitive insight can support more informed conversations, more personalized patient care, and clearer pathways for clinical decisions. Education plays an important role in shaping how cognitive health is understood and addressed across care settings.

Looking ahead to 2026, Cognivue remains focused on expanding awareness, continuing validation efforts and clinician education, and supporting those dedicated to improving cognitive health across diverse populations.

As shared by Cognivue's President & CEO, Paul W. Estes, “Advancing how cognitive performance is measured requires a commitment to education, evidence, and collaboration. In 2025, we made important strides in supporting earlier cognitive insight, and in 2026, we will continue building pathways that help clinicians and researchers better serve patients and communities.”

We are grateful to our partners, collaborators, and team members who contributed to this journey. We enter the new year with focus, optimism, and purpose.